The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Standard Life Board Shake-Up; Morrisons Payout

Wed, 13th Mar 2019 07:50

LONDON (Alliance News) - Stock prices in London are set to open lower on Wednesday, while the pound was steady after UK Prime Minister Theresa May's latest defeat in Parliament over her Brexit deal.Standard Life Aberdeen said it will end its co-chief executive structure. Wm Morrison Supermarkets reported strong annual like-for-like sales growth and topped up the year's special payout. Dixons Carphone was hit by a GBP29 million fine from the UK Financial Conduct Authority. IG says futures indicate the FTSE 100 index of large-caps to open 20.65 points lower at 7,130.50 on Wednesday. The FTSE 100 index closed up 20.53 points, or 0.2%, at 7,151.15 on Tuesday."European equity markets have struggled for direction this week, with the main focus being on the comings and goings between Brussels and London," commented Michael Hewson, chief market analyst at CMC Markets. UK members of Parliament are set to vote on whether to block a no-deal Brexit after May suffered another humiliating defeat over her EU Withdrawal Agreement.Sterling was firm Wednesday morning, quoted at USD1.3114 versus USD1.3083 at the London equities close on Tuesday.MPs from May's Conservative Party will be given a free vote on Wednesday evening on whether they are willing for the UK to leave the EU without a deal at the end of the month.They will vote on a motion stating "this House declines to approve leaving the EU without a Withdrawal Agreement and a framework on the future relationship on March 29".If MPs reject no-deal - as most Westminster observers expect - a third vote will follow on Thursday on whether to authorise May to request an extension of the two-year Article 50 negotiation process.On Tuesday evening, MPs voted by 391 to 242 against the deal despite the prime minister's assurance new agreements reached with Jean-Claude Juncker in Strasbourg would ensure the UK cannot be trapped in the controversial backstop arrangement indefinitely.Although the 149 margin was reduced from the record 230-vote defeat of the first "meaningful vote" in January, May was left far adrift from a majority with just 17 days to go to the scheduled date of Brexit on March 29.The pound was broadly unmoved following the defeat as it came as "no real surprise", said Chris Beauchamp, chief market analyst at IG."Those expecting further gains for the pound will now hope that 'no deal' is ruled out," Beauchamp said, referring to Wednesday evening's vote.In early UK company news, Standard Life Aberdeen said it delivered a "resilient performance" in 2018 despite a challenging backdrop as it set out plans to end its co-chief executive structure.Assets under management and administration totalled GBP551.5 billion at the end of 2018, down from GBP608.1 million at the end of 2017, with net outflows of GBP40.9 billion versus GBP32.9 billion the year before.Consensus had forecast assets under management and administration to be GBP555.8 billion with net outflows of GBP40.3 billion.Adjusted pretax profit from continuing operations slipped to GBP650 million in 2018 from GBP660 million. This was, however, slightly better than the consensus forecast of GBP617 million.Standard Life proposed a final dividend of 14.3p per share, bringing its total for the year to 21.6p, up 1.4% on 2017. In addition to its annual results, the investment firm announced a board shake-up, ending its co-chief executive structure, following the 2017 merger of Standard Life and Aberdeen Asset Management.Keith Skeoch, former head of Standard Life, will become the sole chief executive officer with his co-CEO Martin Gilbert, founder and former head of Aberdeen, to take up the role of vice chair. Meanwhile, Chief Financial Officer Bill Rattray is to step down from Standard Life at the end of May, to be replaced by Stephanie Bruce. Bruce has been a partner in accountant PricewaterhouseCoopers since 2002, Standard Life said. Elsewhere in the FTSE 100, generic drugmaker Hikma swung to a profit in 2018 and lifted its dividend.Revenue for 2018 rose 7% to USD2.07 billion, as the company swung to a pretax profit of USD293 million from a USD738 million loss in 2017. On a core basis, pretax profit grew to USD408 million from USD328 million.Core Injectables revenue rose 40% to USD832 million, while Generics revenue was up 33% to USD692 million and Branded up 26% to USD542 million.In 2019, Injectables revenue is seen between USD850 million to USD900 million. Generics revenue is expected between USD650 million to USD700 million. Branded revenue is to grow "in the mid-single digits in constant currency".Hikma proposed a full-year dividend of 38 cents per share, up from 34 cents the year before. Grocer Wm Morrison Supermarkets reported strong like-for-like sales growth for 2018, though profit slipped. Like-for-like sales were up 4.8% in the year to February 3, accelerating from the 2.8% achieved in the previous financial year and above consensus of 4.5%, as total revenue grew 2.7% to GBP27.7 billion. However, pretax profit slipped 16% to GBP320 million. Stripping out exceptional items, profit rose 8.6% to GBP406 million. The supermarket chain proposed a final dividend of 4.75p, bringing the year's ordinary dividend to 6.60p. On top of this, Morrisons declared a further special dividend of 4.0p, taking its full-year special payout to 6.0p. In total, Morrisons will pay out 12.60p to shareholders for the recently-ended financial year, up 25% on 10.09p the year before.British American Tobacco's Canadian subsidiary received court protection in the tobacco litigation taking place in Quebec, the FTSE 100-listed tobacco major said.Early March, the Court of Appeal in Quebec rejected the appeal by Imperial Tobacco Canada, Rothmans, Benson & Hedges, and JTI-MacDonald Corp against a CAD15.6 billion judgement against them.The case, running since the 1990s, was brought by smokers who alleged the cigarette makers had failed to warn them of the risks associated with smoking.The three are the Canadian subsidiaries of BAT, Philip Morris International, and Japan Tobacco Inc respectively. BAT's Imperial Tobacco Canada is liable for CAD9.2 million of the CAD15.6 billion judgement.BAT said: "Imperial Tobacco Canada has informed us it disagrees with the court's judgment."However, we understand CCAA protection will provide Imperial Tobacco Canada an opportunity to settle all of its outstanding tobacco litigation under an efficient and court-supervised process whilst continuing to run its business in the normal course."Electronics retailer Dixons Carphone said the UK Financial Conduct Authority has fined the company GBP29.1 million following an investigation into Geek Squad mobile phone insurance selling processes The processes, which took place at The Carphone Warehouse between December 2008 to June 2015, were determined by the FCA to have not met expected standards. "We're obviously disappointed that Carphone Warehouse fell short in the past. But we're a very different business today; as the FCA acknowledges, we've made significant improvements since 2015," said Dixons Carphone Chief Executive Alex Baldock.Avast said it had a "successful" year as it swung to a profit, though said its chief executive is to step down. It was the cyber security firm's first annual results since its May 2018 stock market float and subsequent promotion to the FTSE 250 index.Revenue for 2018 rose to USD808.3 million from USD652.9 million, as the firm swung to a USD192.5 million profit from a USD28.9 million loss in 2017. "Looking ahead, we are confident of another good year. Underlying market dynamics remain supportive of Avast's strategy and growth outlook. For the full year 2019 our expectation is high single digit growth for group adjusted revenue, excluding discontinued business and FX, and a stable Ebitda margin percentage," said Chief Executive Vincent Steckler.Meanwhile, the company also said Steckler is to step down on June 30 as CEO and be replaced by president of the Consumer business, Ondrej Vlcek. The Consumer segment is Avast's largest unit.In the US on Tuesday, Wall Street ended mixed, with the Dow Jones Industrial Average ending down 0.4%, weighed down by Boeing. However, the S&P 500 rose 0.3% and Nasdaq Composite closed 0.4% higher. In Asia on Wednesday, the Japanese Nikkei 225 index closed down 1.0%. In China, the Shanghai Composite ended 1.1% lower, while the Hang Seng index in Hong Kong is down 0.5%.In Japan, data showed producer prices were up 0.2% on month in February, exceeding expectations for an increase of 0.1% following the 0.6% decline in January.On a yearly basis, producer prices climbed 0.8% - again exceeding expectations for a gain of 0.7% and up from 0.6% in the previous month.In Wednesday's economic calendar, eurozone industrial production is at 1000 GMT followed by US producer prices at 1230 GMT, with durable goods orders due at the same time. US construction spending is at 1400 GMT.In the UK, Chancellor Phillip Hammond presents his Spring Statement to the House of Commons at 1230 GMT. The event will not hold any new spending or tax measures, but he will communicate the Office for Budget Responsibility's latest borrowing and growth forecasts.

More News
5 Aug 2022 09:43

Barclays downgrades Hikma to 'equalweight' on Generics concerns

(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.

Read more
5 Aug 2022 08:15

LONDON BRIEFING: London Stock Exchange benefits from market volatility

(Alliance News) - London Stock Exchange Group on Friday said results in the first half of 2022 improved, as this year's interim period had an extra month's worth of contribution from recent acquisition Refinitiv.

Read more
4 Aug 2022 17:05

LONDON MARKET CLOSE: Stocks shrug off BoE's UK recession warning

(Alliance News) - Stocks in London managed to end higher on Thursday despite a bleak warning from the Bank of England regarding to outlook for the UK economy as it jacked up rates by 50 basis points.

Read more
4 Aug 2022 12:09

LONDON MARKET MIDDAY: BoE hikes, expects UK recession in 4th quarter

(Alliance News) - London shares price made some gains on Thursday morning, though these fell well short of the market rise seen on mainland Europe, as traders in London showed signs of trepidation leading up to the Bank of England's interest rate decision.

Read more
4 Aug 2022 10:15

Hikma revenue flat, profits tumble in first half

(Sharecast News) - Hikma shares were tumbling on Thursday morning after the pharmaceuticals company reported flat group revenue in its first half, at $1.21bn, as it slashed its guidance on its lagging generics business.

Read more
4 Aug 2022 09:01

LONDON MARKET OPEN: FTSE 100 underperforms amid pre-BoE trepidation

(Alliance News) - The FTSE 100 underperformed European peers and traded sideways in early dealings on Thursday, with the Bank of England to take centre-stage during a week that so far has been dominated by tensions between the US and China.

Read more
4 Aug 2022 09:00

TOP NEWS: Hikma first half hit by stiff competition for Generics

(Alliance News) - Hikma Pharmaceuticals PLC shares suffered on Thursday, as it lowered annual guidance after a poor performance in its Generics business hit half-year profit.

Read more
4 Aug 2022 07:54

LONDON MARKET PRE-OPEN: Next and Serco up outlook but Hikma lowers

(Alliance News) - Stock prices in London are seen opening ever-so-slightly higher, falling short of the more convincing gains seen in Asia, with investors wary ahead of the latest Bank of England interest rate decision.

Read more
28 Jul 2022 16:06

UK earnings, trading statements calendar - next 7 days

Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Senior PLCHalf Year Results
Seraphine Group PLCFull Year Results
Spectris PLCHalf Year Results
XP Power PLCHalf Year Results
Tuesday 2 August 
BP PLCHalf Year Results
Capital & Counties Properties PLCHalf Year Results
Coats Group PLCHalf Year Results
Devro PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Domino's Pizza Group PLCHalf Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Rotork PLCHalf Year Results
Sage Group PLCQ3 Results
Staffline Group PLCHalf Year Results
Synthomer PLCHalf Year Results
Travis Perkins PLCHalf Year Results
Virgin Money UK PLCQ3 Results
Wednesday 3 August 
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Hill & Smith Holdings PLCHalf Year Results
Hiscox LtdHalf Year Results
IP Group PLCHalf year Results
LSL Property Services PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Thursday 4 August 
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.